Heard on the Street Writers Reveal Annual Stock Picks in Eighth Contest Edition Stock Trades Linked to President Trump Prompt Scrutiny Over Potential Conflicts Meta Could Enter Cloud Computing Business as Data Center Overcapacity Looms Zuckerberg Says AMAs 2026 Return to Las Vegas Queen Latifah Hosts BTS Appearance Could Boost Media and Tourism AST SpaceMobile and Rocket Lab A Comparative Analysis for 2026 Genpact CEO Suggests AI Could Reduce IT Workload and Slow Job Growth UEC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Progress FLNA Q3 2025 Earnings NarrowerThanExpected Loss Drives Stock Rally Nike NKE Q1 2026 Earnings EPS Surges Past Estimates with 2289 Beat Daxor Corporation DXR Q3 2007 Earnings Landmark EPS Beat Lifts Sentiment Despite No Revenue Disclosure Legacy Education Inc LGCY Q1 2026 Earnings Strong EPS Beat Despite Revenue Headwinds and Stock Pullback Almonty Industries Inc Q1 2026 Earnings EPS Misses Estimates by Wide Margin AZZ Inc AZZ Consolidates Near Resistance After Slight Decline aTyr Pharma ATYR Slides 27 Approaching Key Support at 048 Telomir Pharmaceuticals TELO Holds Steady at 129 as Consolidation Persists SREA Holds Steady Near 2120 as FixedIncome Investors Eye Yield Haverty Furniture HVT Sees Slight Decline Holds Near Support Levels Wall Street Rallies Dow Achieves Record High Amid Optimism Over Middle East Situation Nordson Q1 2026 Earnings Narrow EPS Miss Fails to Derail Investor Confidence Stantec Inc STN Edges Higher With Modest Uptick as Sector Eyes Infrastructure Demand IAG Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Negatively CXW Q1 2026 Earnings CoreCivic Reports EPS Beat Stock Rises ICON Q4 2025 Earnings EPS Misses Estimates Amidst Operational Challenges Cathay General Bancorp CATY Q1 2026 Earnings Strong EPS Surprise of 2275 Drives Profit Beat Despite Stock Dip GNLN Q2 2023 Earnings Significant Loss Per Share Misses Estimates Stock Declines DCBO Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Gains Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline